Literature DB >> 20961644

Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease.

Zoltan Derdak1, Charles H Lang, Kristine A Villegas, Ming Tong, Nicholas M Mark, Suzanne M de la Monte, Jack R Wands.   

Abstract

BACKGROUND & AIMS: Chronic ethanol consumption in the Long-Evans (LE) rat has been associated with hepatic p53 activation, and inhibition of the insulin/PI3K/AKT signal transduction cascade due to increased expression of PTEN. We hypothesize that p53 activation and altered insulin signaling may influence the susceptibility of rats to ethanol-induced liver damage. Furthermore, p53 not only activates programmed cell death pathways and suppresses hepatocellular survival signals, but also promotes gluconeogenesis to increase systemic insulin resistance due to a novel metabolic function.
METHODS: Fischer (F), Sprague-Dawley (SD) and LE rats were fed ethanol-containing or control liquid diet for 8 weeks. Histopathological and biochemical changes were assessed.
RESULTS: Here, we demonstrate that chronic ethanol feeding in rats promotes p53 activation, hepatic steatosis, oxidative stress, PUMA, and PTEN expression, which contribute to hepatocellular death and diminished insulin signaling in the liver. Such changes are pronounced in the LE, less prominent in SD, and virtually absent in the F rat strain. More importantly, there is activation of Tp53-induced glycolysis and apoptosis regulator (TIGAR) in the ethanol-fed LE rat. This event generates low hepatic fructose-2,6-bisphosphate (Fru-2,6-P₂) levels, reduced lactate/pyruvate ratio and may contribute to increased basal glucose turnover and high residual hepatic glucose production during euglycemic hyperinsulinemic clamp.
CONCLUSIONS: p53 activation correlates with the susceptibility to ethanol-induced liver damage in different rat strains. p53 not only orchestrates apoptosis and suppresses cell survival, but by activating TIGAR and decreasing hepatic Fru-2,6-P₂) levels it promotes insulin resistance and therefore, contributes to the metabolic abnormalities associated with hepatic steatosis.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961644      PMCID: PMC2994971          DOI: 10.1016/j.jhep.2010.08.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  33 in total

1.  Mitochondrial DNA deletion mutations are concomitant with ragged red regions of individual, aged muscle fibers: analysis by laser-capture microdissection.

Authors:  Z Cao; J Wanagat; S H McKiernan; J M Aiken
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

2.  A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis.

Authors:  Mirella Trinei; Marco Giorgio; Angelo Cicalese; Sara Barozzi; Andrea Ventura; Enrica Migliaccio; Elisabetta Milia; Ines Martin Padura; Veronica A Raker; Marco Maccarana; Valeria Petronilli; Saverio Minucci; Paolo Bernardi; Luisa Lanfrancone; Pier Giuseppe Pelicci
Journal:  Oncogene       Date:  2002-05-30       Impact factor: 9.867

3.  Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver.

Authors:  Jong Eun Yeon; Sophia Califano; Julia Xu; Jack R Wands; Suzanne M De La Monte
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

4.  Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.

Authors:  C H Lang; C Dobrescu; G J Bagby
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

5.  An endpoint enzymatic assay for fructose 2,6-bisphosphate performed in 96-well plates.

Authors:  P Bruni; V Vasta; M Farnararo
Journal:  Anal Biochem       Date:  1989-05-01       Impact factor: 3.365

6.  Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP).

Authors:  Min You; Monika Fischer; Mark A Deeg; David W Crabb
Journal:  J Biol Chem       Date:  2002-05-29       Impact factor: 5.157

7.  Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells.

Authors:  P M Hwang; F Bunz; J Yu; C Rago; T A Chan; M P Murphy; G F Kelso; R A Smith; K W Kinzler; B Vogelstein
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

Review 8.  Molecular basis of mitochondrial DNA disease.

Authors:  M D Brown; D C Wallace
Journal:  J Bioenerg Biomembr       Date:  1994-06       Impact factor: 2.945

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  SREBPs suppress IRS-2-mediated insulin signalling in the liver.

Authors:  Tomohiro Ide; Hitoshi Shimano; Naoya Yahagi; Takashi Matsuzaka; Masanori Nakakuki; Takashi Yamamoto; Yoshimi Nakagawa; Akimitsu Takahashi; Hiroaki Suzuki; Hirohito Sone; Hideo Toyoshima; Akiyoshi Fukamizu; Nobuhiro Yamada
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

View more
  47 in total

1.  MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1.

Authors:  Huquan Yin; Ming Hu; Ray Zhang; Zheng Shen; Laura Flatow; Min You
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  J Liver       Date:  2013

3.  Restoration of Wnt/β-catenin signaling attenuates alcoholic liver disease progression in a rat model.

Authors:  Chiung-Kuei Huang; Tunan Yu; Suzanne M de la Monte; Jack R Wands; Zoltan Derdak; Miran Kim
Journal:  J Hepatol       Date:  2015-02-24       Impact factor: 25.083

4.  Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance.

Authors:  Suzanne M de la Monte; Maoyin Pang; Rajeev Chaudhry; Kevin Duan; Lisa Longato; Jade Carter; Jiyun Ouh; Jack R Wands
Journal:  Hepatol Res       Date:  2011-02-24       Impact factor: 4.288

5.  Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.

Authors:  Diana Lizarazo; Valerie Zabala; Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

6.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

Review 7.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

8.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

Review 9.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

10.  Strain-dependent differences for suppression of insulin-stimulated glucose uptake in skeletal and cardiac muscle by ethanol.

Authors:  Charles H Lang; Zoltan Derdak; Jack R Wands
Journal:  Alcohol Clin Exp Res       Date:  2014-01-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.